Cas 1009563-53-4,N'1,N'3-dimethyl-N'1,N'3-di(phenylcarbonothionyl)-2-(2-phenylhydrazono)-malonohydrazine

1009563-53-4

Post Buying Request

Basic information

Product Name: N'1,N'3-dimethyl-N'1,N'3-di(phenylcarbonothionyl)-2-(2-phenylhydrazono)-malonohydrazine
Synonyms: N'1,N'3-dimethyl-N'1,N'3-di(phenylcarbonothionyl)-2-(2-phenylhydrazono)-malonohydrazine
CAS NO:1009563-53-4
Molecular Formula:
Molecular Weight: 504.637
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: N'1,N'3-dimethyl-N'1,N'3-di(phenylcarbonothionyl)-2-(2-phenylhydrazono)-malonohydrazine(CAS DataBase Reference)
NIST Chemistry Reference: N'1,N'3-dimethyl-N'1,N'3-di(phenylcarbonothionyl)-2-(2-phenylhydrazono)-malonohydrazine(1009563-53-4)
EPA Substance Registry System: N'1,N'3-dimethyl-N'1,N'3-di(phenylcarbonothionyl)-2-(2-phenylhydrazono)-malonohydrazine(1009563-53-4)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 1009563-53-4(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

1009563-53-4 Suppliers

Recommended suppliers

1009563-53-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1009563-53-4 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,0,9,5,6 and 3 respectively; the second part has 2 digits, 5 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1009563-53:
(9*1)+(8*0)+(7*0)+(6*9)+(5*5)+(4*6)+(3*3)+(2*5)+(1*3)=134
134 % 10 = 4
So 1009563-53-4 is a valid CAS Registry Number.

1009563-53-4Upstream product

1009563-53-4Downstream Products

1009563-53-4Relevant academic research and scientific papers

COMPOUNDS FOR TREATING PROLIFERATIVE DISORDERS

-

Page/Page column 130-131, (2008/06/13)

Disclosed are compounds and methods, of using compounds of the invention for treating a subject with a proliferative disorder, such as cancer, and methods for treating disorders responsive to Hsp70 induction and/or natural killer induction. Also, disclosed are pharmaceutical compositions comprising compounds of the invention and a pharmaceutically acceptable carrier.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 1009563-53-4